Q4-19 Report English
Year-end report 2019 Good conclusion to a strong year Fourth quarter 2019 January-December 2019 • Consolidated net sales amounted to SEK 30,850 million (30,069), an increase of 2.6% • Consolidated net sales amounted to SEK 119,295 million (115,354), an increase of 3.4% • Operating profit excluding items affecting comparability was SEK 1,267 million (1,139). Recalculated for IFRS 16, operating profit for the • Operating profit excluding items affecting comparability was SEK 5,356 comparison period in 2018 was SEK 1,180 million million (4,651). Recalculated for IFRS 16, operating profit for the comparison period in 2018 was 4,811 million • Operating profit includes nonrecurring items in ICA Sweden of approximately SEK -50 million. Operating profit for ICA Sweden for the • Profit for the period was SEK 3,450 million (3,647). Profit includes capital same period a year ago included structural costs of SEK -110 million losses on sales of non-current assets and impairment losses totalling SEK -422 million net (-153), of which SEK -382 million pertains to the sale of • Profit for the period was SEK 915 million (930) Hemtex • Profit includes capital losses on sales of non-current assets and • Earnings per share were SEK 17.06 (18.05) impairment losses totalling SEK -18 million net (33) • Cash flow from operating activities was SEK 9,748 million (6,802). • Earnings per share were SEK 4.52 (4.61) Excluding ICA Bank, cash flow was SEK 9,923 million (6,555). The • Cash flow from operating activities was SEK 3,096 million (2,244).
[Show full text]